Browse diseases

…Background Migraine is a common comorbidity in patients with cervical dystonia (CD); however, the diagnosis of chronic migraine (CM) in patien…

…sis (PsO), psoriatic arthritis (PsA), Crohn’s disease (CD), and ulcerative colitis (UC).To evaluate treatment in a real-world setting, drug persis…

…all our committee with 19 different indications. The second was chest disease (CD) (18 indications for 103 patients) and haematology the thir…

… a measure of CD activity, and the efficacy of SC guselkumab in CD.…

…d Ustekinumab (anti-IL12/23) are approved treatments for active Crohn’s Disease (CD). Given the increasing use of sequential biologic therapies…

…ekinumab is an effective treatment for Crohn’s disease (CD) and ulcerative colitis (UC). The advent of biosimilar ustekinumab in 2024 and potentia…

…16.5 years; mean Burke-Fahn-Marsden (BFM) 32.9±14.1) and 7 with CD (4 females; mean age, 46.2±9.8 years; mean BFM 10.4±4.4). Param…

…Introduction The optimal treatment target for Crohn’s disease (CD) is unknown. Targeting transmural healing (TMH) may be asso…

…nterleukin-23 p19 subunit inhibitor which received approval for Crohn’s disease (CD) by UK licensing authorities in May 2023. Our aim was to ev…

…t Janus kinase inhibitor and oral advanced therapy licensed for Crohn’s disease (CD). Following NICE approval in 2023, real-world data on outco…

…changes (first (D1) versus second part of the duodenum (D2)) in paediatric coeliac disease (CD).Methods A retrospective review of the departmental CD data…

…nce in non-responsive (NRCD), refractory (RCD), and complicated coeliac disease (CCD) has not been systematically evaluated. Current guidelines…